Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)
- Substances:BortezomibDexamethasone+4
Spain- Participants:0–17 years
- Substances:Bortezomib
- Sponsor:Charite Universitaetsmedizin Berlin KöR
Rare diseases
Investigational molecules
Locations
Edificio Gris, Avenida Pintor Baeza 12, 03010 Alicante, Spain
Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria Y Biomedica De Alicante in Alicante, Spain specialises in clinical trials of conditions such as Neoplasm, Pulmonary embolism, and other specialisations. This site conducts important research.
The medical center is at the forefront of pulmonary imaging and diagnostics, focusing on enhancing the diagnostic accuracy of pulmonary CT angiography. This specialization is driven by ongoing research into optimizing iodinated contrast administration protocols to improve the detection and assessment of pulmonary embolism.
Through innovative approaches, the center contributes significantly to the development of more precise and effective diagnostic tools, ultimately improving patient outcomes in the management of pulmonary conditions.
Clinical trials currently enrolling participants at this site.
SpainA study to compare using a half dose of iomeprol versus a standard dose of iomeprol for imaging lung tumors with spectral CT scans.
SpainStudy on Pulmonary Embolism: Comparing Iomeprol Dosages in CT Scans for Patients with Suspected Pulmonary Embolism
SpainGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.